Moreover, the results determined a slight decrease in tumor-infiltrating CD4+CD25+Foxp3+ T cells in the TEXomiR group compared with TEX; however, it did not reach a statistically significant threshold (P = 0.071) (Figure 9B). The gene discussed is FOXP3; the disease is neoplasm.